Molecular mechanisms underlying nutrient-stimulated incretin secretion
- PMID: 20047700
- DOI: 10.1017/S146239940900132X
Molecular mechanisms underlying nutrient-stimulated incretin secretion
Abstract
The incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are released from enteroendocrine cells in the intestinal epithelium in response to nutrient ingestion. The actions of GLP-1 and GIP - not only on local gut physiology but also on glucose homeostasis, appetite control and fat metabolism - have made these hormones an attractive area for drug discovery programmes. The potential range of strategies to target the secretion of these hormones therapeutically has been limited by an incomplete understanding of the mechanisms underlying their release. The use of organ and whole-animal perfusion techniques, cell line models and primary L- and K-cells has led to the identification of a variety of pathways involved in the sensing of carbohydrate, fat and protein in the gut lumen. This review focuses on our current understanding of these signalling mechanisms that might underlie nutrient responsiveness of L- and K-cells.
Similar articles
-
Molecular mechanisms of incretin hormone secretion.Curr Opin Pharmacol. 2013 Dec;13(6):922-7. doi: 10.1016/j.coph.2013.08.013. Epub 2013 Sep 10. Curr Opin Pharmacol. 2013. PMID: 24035446 Free PMC article. Review.
-
Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.Am J Physiol Gastrointest Liver Physiol. 2020 Jul 1;319(1):G23-G35. doi: 10.1152/ajpgi.00189.2019. Epub 2020 May 18. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 32421358 Free PMC article.
-
Molecular mechanisms underlying nutrient detection by incretin-secreting cells.Int Dairy J. 2010 Apr;20(4):236-242. doi: 10.1016/j.idairyj.2009.11.014. Int Dairy J. 2010. PMID: 20204054 Free PMC article.
-
Nutrition and L and K-enteroendocrine cells.Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):35-41. doi: 10.1097/MED.0b013e32834190b5. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21124210 Free PMC article. Review.
-
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.Diabetes Obes Metab. 2021 Sep;23 Suppl 3:5-29. doi: 10.1111/dom.14496. Diabetes Obes Metab. 2021. PMID: 34310013 Review.
Cited by
-
Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome.Exp Ther Med. 2016 Sep;12(3):1398-1404. doi: 10.3892/etm.2016.3491. Epub 2016 Jun 30. Exp Ther Med. 2016. PMID: 27588061 Free PMC article.
-
S1P Signaling Pathways in Pathogenesis of Type 2 Diabetes.J Diabetes Res. 2021 Jan 19;2021:1341750. doi: 10.1155/2021/1341750. eCollection 2021. J Diabetes Res. 2021. PMID: 34751249 Free PMC article.
-
Spatiotemporal Modeling of Triggering and Amplifying Pathways in GLP-1 Secreting Intestinal L Cells.Biophys J. 2017 Jan 10;112(1):162-171. doi: 10.1016/j.bpj.2016.11.3199. Biophys J. 2017. PMID: 28076808 Free PMC article.
-
Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells.J Physiol. 2011 Mar 1;589(Pt 5):1081-93. doi: 10.1113/jphysiol.2010.198069. Epub 2011 Jan 4. J Physiol. 2011. PMID: 21224236 Free PMC article.
-
GLP-1 and energy balance: an integrated model of short-term and long-term control.Nat Rev Endocrinol. 2011 Jun 7;7(9):507-16. doi: 10.1038/nrendo.2011.77. Nat Rev Endocrinol. 2011. PMID: 21647189 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources